Physiological effects of high-flow nasal cannula oxygen therapy after extubation: a randomized crossover study.
Roque BasoaltoL Felipe DamianiYorschua JalilMaría Consuelo BachmannVanessa OviedoLeyla AlegríaEmilio Daniel ValenzuelaMaximiliano RovegnoPablo Ruiz-RudolphRodrigo CornejoJaime RetamalGuillermo BugedoArnaud W ThilleAlejandro BruhnPublished in: Annals of intensive care (2023)
Prophylactic application of HFNC after extubation provides substantial respiratory support and unloads respiratory muscles. Trial registration January 15, 2021. NCT04711759.
Keyphrases
- respiratory failure
- cardiac surgery
- mechanical ventilation
- extracorporeal membrane oxygenation
- study protocol
- clinical trial
- respiratory tract
- phase iii
- acute kidney injury
- acute respiratory distress syndrome
- intensive care unit
- randomized controlled trial
- stem cells
- positive airway pressure
- obstructive sleep apnea
- mesenchymal stem cells
- placebo controlled